Immunologically, there was a significant decrease in serum total IgE (Figure 3f) and IL-4 levels (Figure 3g) in the ACext treated group, suggesting a reduction in the allergic and inflammatory responses associated with AD. The gene discussed is IGHE; the disease is Alzheimer disease.